While industry observers widely believed astrazeneca

June 30, 2010 by Editor · Leave a Comment
Filed under: Drug 

Judge Joseph Farnan, of the U.S. District Court in Delaware, ruled that generic drugmakers who challenged the patent failed to prove it was invalid because it was an obvious invention.
Farnan also ruled that defendants have not established, by clear and convincing evidence, that the 314 patent is invalid as an improper reissue of an older [...]

Fda said research showed mixing antibiotics livestock

June 29, 2010 by Aleccia Yule · Leave a Comment
Filed under: FDA 

Over-the-counter antibiotics have been routinely used for decades to promote livestock growth and feed efficiency.
Emergence of antibiotic-resistant bacteria poses a serious public health threat, said FDA, so it is looking for ways to reduce overuse of the drugs.
Antibiotics including penicillin and tetracyclines should be used only under the supervision of veterinarians to prevent or [...]

The researchers hope figurecalculated for first time will

June 29, 2010 by Johnson Anders · Leave a Comment
Filed under: Cancer 

The researchers hope this figurecalculated for the first time — will help make health care providers more aware of these families and provide them with additional support.
I think people have vastly underestimated the number of children who are affected by a parents cancer, Dr. Paula Rauch, who was not involved in the study, told Reuters [...]

The results study british researchers call into question

June 29, 2010 by Johnson Anders · Leave a Comment
Filed under: Heart 

Statins are one of the most widely used drugs for the treatment and prevention of heart disease, both among people who already have it and among high-risk but healthy people. They are among the most successful drugs of all time and have been credited with preventing millions of heart attacks and strokes.
But in a meta-analysisa [...]

The conflicting results were released on monday

June 29, 2010 by Editor · Leave a Comment
Filed under: Drug 

The medicine was Glaxos second-biggest drug but is much smaller after a safety controversy erupted three years ago.
One analysis of 56 clinical trials found Avandia increased the chances of a heart attack by 28 percent to 39 percent, researchers at the Cleveland Clinic in Ohio said in an update to a 2007 study that [...]

The consortium of researchers from across europe

June 28, 2010 by Philbert Ross · Leave a Comment
Filed under: Diabetes 

The signals we have identified provide important clues to the biological basis of type 2 diabetes. The challenge will be to turn these genetic findings into better ways of treating and preventing the condition, said Mark McCarthy of the center for human genetics at Oxford University, who led the study.
Type 2 diabetes is caused by [...]

Cows milk protein allergy most common and most dangerous

June 26, 2010 by Editor · Leave a Comment
Filed under: Allergy 

The finding that giving cows milk very early in life might boost tolerance came as a surprise to lead researcher Dr. Yitzhak Katz of Tel Aviv University in Israel. He and his colleagues simply set out to improve on current estimates of the number of children with the allergy, and to determine how often it [...]

The european medicines agency said its committee

June 26, 2010 by Editor · Leave a Comment
Filed under: Drug 

The study, known as a meta-analysis and published by U.S. researchers earlier this month, looked at all the publicly available data and found that patients were 1.2 percent more likely to be diagnosed with a new cancer over four years than people who did not take the drugs.
The CHMP will review the meta-analysis thoroughly, together [...]

They said estimated percent dietary sodium comes from

June 25, 2010 by Editor · Leave a Comment
Filed under: Food 

Sodium has become so pervasive in our food supply that its difficult for the vast majority of Americans to stay within recommended limits, said Janelle Peralez Gunn, public health analyst with the U.S. Centers for Disease Control and Prevention who led the study of salt consumption.
Public health professionals, together with food manufacturers, retailers and healthcare [...]

The findings could bring cost of immunization

June 24, 2010 by Philbert Ross · Leave a Comment
Filed under: Vaccine 

A needle-free jet injector made by Bioject Medical Technologies was used to deliver the vaccine beneath the skin at ages 2, 4 and 6 months. Blood tests showed more than 95 percent of the infants mounted an effective immune response against polio.
Babies who got a lower dose had fewer antibodies against polio but the researchers [...]

« Previous PageNext Page »